Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients
Links shared publicly online about this topic.
- 1,830total visits
Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients
Patients with stage III or IV melanoma taking ipilimumab and the oral steroid budesonide to reduce side effects did not have less diarrhea, a known side effect of ipilimumab, according to results of a phase II trial published in Clinical Cancer Research, a journal of the American Association for Cancer ...
View full resource at physorg.com
Tags: Asthma Medication, Diarrhea, Cancer, Skin Cancer, Melanoma, Pulmicort
Most Recently Shared on August 11, 2009 at 9:51 pm By:
Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients http://bit.ly/YxTBQ
Budesonide is Not Beneficial for the Treatment of Diarrhea in Metastatic Melanoma Patients Receiving Ipilimumab
newswise.com — “1) Oral budesonide does not change gastrointestinal side effects; 2) Diarrhea occurred in 32.7 percent of patients using the drug; 3) The median 12 and 18 month survivals were excellent and favorable.” View full resource at newswise.com
Most Recently Shared on August 12, 2009 at 1:53 am By:
Budesonide is Not Beneficial for the Treatment of Diarrhea in Metastatic Melanoma Patients Receiving Ipilimumab http://bit.ly/RlJGv
Advertisement
